跳至主要内容
临床试验/IRCT138808182685N1
IRCT138808182685N1已完成3 期

The effect of low-dose oral Theophylline on serum HS-CRP in patients with stable COPD

Vice-chancellor for Research, Kurdistan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • stable COPD (no exacerbation in the past two months), FEV1/FVC ratio less than 70%.
  • Exclusion criteria: no smoking history, FEV1 increased more than 200 cc or 12% after administration of 400 micrograms spray Salbutamol in spirometry, clinical or radiographic evidence of pneumonia, history of infectious disease such as tuberculosis, recent respiratory tract infections, bronchiectasis, acute or chronic diarrhea, rheumatoid arthritis, degenerative disease of large joint, vasculitis, and the possibility of malignancy based on history and examination and Theophylline use during a month prior to the enrollment

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for Research, Kurdistan University of Medical Sciences

相似试验